Results 1 to 10 of about 239,135 (329)

Gender differences in depression and anxiety among atopic dermatitis patients

open access: diamondIndian Journal of Dermatology, 2015
Background: Dermatological patients invariably suffer one or the other psychological problems which may escalate to the extent of a mental disorder. One of the most common dermatological disorders is atopic dermatitis (AD), but the literature has limited
Shaily Mina   +3 more
doaj   +2 more sources

Depression, Anxiety and Quality of Life in Patients with Atopic Dermatitis and Psoriasis [PDF]

open access: yesMedicina
Background and Objectives: Atopic dermatitis and psoriasis are life-long inflammatory diseases affecting more than just the skin. Although their link with mental comorbidities has been established, the role of using self-assessment questionnaires is ...
Arina Arnīte   +4 more
doaj   +2 more sources

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

open access: yesNature reviews. Drug discovery, 2021
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies.
T. Bieber
semanticscholar   +1 more source

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

open access: yesActa Dermato-Venereologica, 2023
Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes   +8 more
doaj   +1 more source

Molecular Mechanisms of Atopic Dermatitis Pathogenesis

open access: yesInternational Journal of Molecular Sciences, 2021
Atopic dermatitis is a chronic, non-infectious inflammatory dermatosis. Acharacteristic feature is persistent itching of the skin. The chronic, relapsing course of the disease, economic burden, and the whole family’s involvement in the treatment process ...
Jowita Sroka-Tomaszewska, M. Trzeciak
semanticscholar   +1 more source

Oral food challenges in children [PDF]

open access: yesKorean Journal of Pediatrics, 2011
Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum   +9 more
doaj   +1 more source

Quality of Life of Allergic Dogs Treated with Allergen-Specific Immunotherapy—A Retrospective Study

open access: yesVeterinary Sciences, 2023
Background: The quality of life (QoL) of dogs with canine atopic dermatitis (CAD) treated with allergen-specific immunotherapy (ASIT) was studied to determine whether the QoL of dogs treated with ASIT (AG) improved compared with dogs not treated with ...
Tina Kotnik
doaj   +1 more source

IL1RL1 single nucleotide polymorphisms are associated with asthma in the Iranian population

open access: yesMonaldi Archives for Chest Disease, 2021
Asthma is a chronic and multifactorial disease which is known to result from environmental and genetic factors. Interleukin 1 receptor-like 1 (IL1RL1) is a receptor, which promotes inflammatory responses after binding to its ligand IL-33. Several studies
Maral Ranjbar   +5 more
doaj   +1 more source

Harmful Effects of Ambient Nitrogen Dioxide on Atopic Dermatitis: Comparison of Exposure Assessment Based on Monitored Concentrations and Modeled Estimates

open access: yesAtmosphere, 2020
Precise exposure assessment of air pollutants is crucial in epidemiologic studies to ensure valid estimates of health effects. We conducted a longitudinal study to evaluate the role of air quality monitoring (AQM) measurements and high-resolution ...
Young-Min Kim   +4 more
doaj   +1 more source

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND The oral Janus kinase 1 (JAK1) inhibitor abrocitinib, which reduces interleukin-4 and interleukin-13 signaling, is being investigated for the treatment of atopic dermatitis. Data from trials comparing JAK1 inhibitors with monoclonal antibodies,
T. Bieber   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy